Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$hrow](/topic/$hrow)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$hrow/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$hrow/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% +9%  
**1 Month**: XX% +5%  
**1-Year High**: XXX% on 2025-04-28  
**1-Year Low**: XX% on 2025-09-09  

**Most Supportive Themes**
- **Bullish on Growth and Value:** (45%) Many posts highlight $HROW's strong revenue and EBITDA growth, with analysts and investors seeing it as undervalued.
- **Positive Portfolio Mentions:** (30%) $HROW is frequently mentioned in lists of favorite stocks and investment portfolios, indicating strong investor interest.
  
**Most Critical Themes**
- **Regulatory Concerns:** (25%)  The California Board of Pharmacy's amended accusation against $HROW's subsidiaries regarding quality control and compliance issues is a concern.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXXX   | XX% | XXXXX   | XX% | XXX      | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXXX   | XX% | XXXXX   | XX% | XXX      | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$hrow

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +9%
1 Month: XX% +5%
1-Year High: XXX% on 2025-04-28
1-Year Low: XX% on 2025-09-09

Most Supportive Themes

  • Bullish on Growth and Value: (45%) Many posts highlight $HROW's strong revenue and EBITDA growth, with analysts and investors seeing it as undervalued.
  • Positive Portfolio Mentions: (30%) $HROW is frequently mentioned in lists of favorite stocks and investment portfolios, indicating strong investor interest.

Most Critical Themes

  • Regulatory Concerns: (25%) The California Board of Pharmacy's amended accusation against $HROW's subsidiaries regarding quality control and compliance issues is a concern.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXXX XX% XXXXX XX% XXX X%
Total XXXXXX XX% XXXXX XX% XXX X%
$hrow Sentiment
/topic/$hrow/sentiment